361 related articles for article (PubMed ID: 19168026)
1. The role of the mitochondrial permeability transition pore in heart disease.
Halestrap AP; Pasdois P
Biochim Biophys Acta; 2009 Nov; 1787(11):1402-15. PubMed ID: 19168026
[TBL] [Abstract][Full Text] [Related]
2. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.
Halestrap AP
Biochem Soc Trans; 2010 Aug; 38(4):841-60. PubMed ID: 20658967
[TBL] [Abstract][Full Text] [Related]
3. What is the mitochondrial permeability transition pore?
Halestrap AP
J Mol Cell Cardiol; 2009 Jun; 46(6):821-31. PubMed ID: 19265700
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.
Leung AW; Varanyuwatana P; Halestrap AP
J Biol Chem; 2008 Sep; 283(39):26312-23. PubMed ID: 18667415
[TBL] [Abstract][Full Text] [Related]
5. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
Clarke SJ; McStay GP; Halestrap AP
J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore.
Leung AW; Halestrap AP
Biochim Biophys Acta; 2008; 1777(7-8):946-52. PubMed ID: 18407825
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases.
Javadov S; Karmazyn M; Escobales N
J Pharmacol Exp Ther; 2009 Sep; 330(3):670-8. PubMed ID: 19509316
[TBL] [Abstract][Full Text] [Related]
8. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.
Halestrap AP; Richardson AP
J Mol Cell Cardiol; 2015 Jan; 78():129-41. PubMed ID: 25179911
[TBL] [Abstract][Full Text] [Related]
9. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death.
Halestrap AP; Brenner C
Curr Med Chem; 2003 Aug; 10(16):1507-25. PubMed ID: 12871123
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart.
Halestrap AP; Kerr PM; Javadov S; Woodfield KY
Biochim Biophys Acta; 1998 Aug; 1366(1-2):79-94. PubMed ID: 9714750
[TBL] [Abstract][Full Text] [Related]
11. The permeability transition pore complex: another view.
Halestrap AP; McStay GP; Clarke SJ
Biochimie; 2002; 84(2-3):153-66. PubMed ID: 12022946
[TBL] [Abstract][Full Text] [Related]
12. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
Schriewer JM; Peek CB; Bass J; Schumacker PT
J Am Heart Assoc; 2013 Apr; 2(2):e000159. PubMed ID: 23598272
[TBL] [Abstract][Full Text] [Related]
13. Not all mitochondrial carrier proteins support permeability transition pore formation: no involvement of uncoupling protein 1.
Crichton PG; Parker N; Vidal-Puig AJ; Brand MD
Biosci Rep; 2009 Dec; 30(3):187-92. PubMed ID: 19622065
[TBL] [Abstract][Full Text] [Related]
14. The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore.
Lim SY; Davidson SM; Mocanu MM; Yellon DM; Smith CC
Cardiovasc Drugs Ther; 2007 Dec; 21(6):467-9. PubMed ID: 17965927
[TBL] [Abstract][Full Text] [Related]
15. To involvement the conformation of the adenine nucleotide translocase in opening the Tl(+)-induced permeability transition pore in Ca(2+)-loaded rat liver mitochondria.
Korotkov SM; Konovalova SA; Brailovskaya IV; Saris NE
Toxicol In Vitro; 2016 Apr; 32():320-32. PubMed ID: 26835787
[TBL] [Abstract][Full Text] [Related]
16. Targeting the mitochondrial permeability transition pore for drug discovery: Challenges and opportunities.
Boyenle ID; Oyedele AK; Ogunlana AT; Adeyemo AF; Oyelere FS; Akinola OB; Adelusi TI; Ehigie LO; Ehigie AF
Mitochondrion; 2022 Mar; 63():57-71. PubMed ID: 35077882
[TBL] [Abstract][Full Text] [Related]
17. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice.
Elrod JW; Wong R; Mishra S; Vagnozzi RJ; Sakthievel B; Goonasekera SA; Karch J; Gabel S; Farber J; Force T; Brown JH; Murphy E; Molkentin JD
J Clin Invest; 2010 Oct; 120(10):3680-7. PubMed ID: 20890047
[TBL] [Abstract][Full Text] [Related]
18. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
Lim SY; Davidson SM; Hausenloy DJ; Yellon DM
Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.
Bell RM; Kunuthur SP; Hendry C; Bruce-Hickman D; Davidson S; Yellon DM
Basic Res Cardiol; 2013 Mar; 108(2):331. PubMed ID: 23361433
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury.
Kim SY; Shim MS; Kim KY; Weinreb RN; Wheeler LA; Ju WK
Cell Death Dis; 2014 Mar; 5(3):e1105. PubMed ID: 24603333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
